R. Morley

发表

Fundamental Studies on Brooker's Merocyanine

J. O. Morley, R. Morley, R. Docherty, 1997 .

Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

G. Collingridge, D. Jane, D. Monaghan, 2012, Journal of medicinal chemistry.

Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists.

H. Tse, D. Jane, D. Monaghan, 2005, Journal of medicinal chemistry.

Newly identified structurally disparate modulators of osmosensitive taurine efflux inhibit cell cycle progression.

R. Morley, H. Witchel, S. Culliford, 2003, European journal of pharmacology.

N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse

D. Jane, D. Monaghan, N. Lozovaya, 2009, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.

G. Collingridge, D. Jane, Z. Bortolotto, 2005, Journal of medicinal chemistry.

N-Methyl-D-aspartate ( NMDA ) Receptor NR 2 Subunit Selectivity of a Series of Novel Piperazine-2 , 3-dicarboxylate Derivatives : Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA 3-CA 1 Synapse

D. Jane, D. Monaghan, N. Lozovaya, 2009 .

Identification of Subunit- and Antagonist-Specific Amino Acid Residues in the N-Methyl-d-aspartate Receptor Glutamate-Binding Pocket

D. Skifter, D. Jane, D. Monaghan, 2005, Journal of Pharmacology and Experimental Therapeutics.

The effect of competitive antagonist chain length on NMDA receptor subunit selectivity

D. Jane, D. Monaghan, Bihua Feng, 2005, Neuropharmacology.

Identification of subunit-specific and antagonist-specific amino acid residues in the NMDA receptor glutamate binding pocket

D. Skifter, D. Jane, D. Monaghan, 2005 .

Structure–activity analysis of a novel NR2C/NR2D‐preferring NMDA receptor antagonist: 1‐(phenanthrene‐2‐carbonyl) piperazine‐2,3‐dicarboxylic acid

H. Tse, D. Skifter, D. Jane, 2004, British journal of pharmacology.

Temperature regulation in biotelemetered spontaneously hypertensive rats.

A. Vander, R. Morley, M. Kluger, 1990, The American journal of physiology.

Spectroscopic Studies on Brooker's Merocyanine

J. O. Morley, R. Morley, Ann L. Fitton, 1998 .